ticlopidine has been researched along with Neointima in 11 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Neointima: The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to compare the effects of ticagrelor and clopidogrel on early neointimal healing assessed with optical coherence tomography (OCT) after drug-eluting stent (DES) implantation in patients with acute myocardial infarction (AMI)." | 9.27 | Randomized Comparison of Strut Coverage between Ticagrelor and Clopidogrel in Acute Myocardial Infarction at 3-Month Optical Coherence Tomography. ( Ahn, CM; Choi, D; Hong, MK; Hong, SJ; Jang, Y; Kim, BK; Kim, C; Kim, JS; Ko, YG, 2018) |
| "Compared to clopidogrel and prasugrel, ticagrelor reduced neointimal formation, endothelial dysfunction, and peri-strut inflammation." | 7.85 | Effects of ticagrelor on neointimal hyperplasia and endothelial function, compared with clopidogrel and prasugrel, in a porcine coronary stent restenosis model. ( Chang, KS; Hong, YJ; Jeong, MH; Kim, HK; Kim, JH; Kim, MC; Kim, SS; Lim, HC; Lim, KS; Park, KH, 2017) |
| "This study aimed to compare the effects of ticagrelor and clopidogrel on early neointimal healing assessed with optical coherence tomography (OCT) after drug-eluting stent (DES) implantation in patients with acute myocardial infarction (AMI)." | 5.27 | Randomized Comparison of Strut Coverage between Ticagrelor and Clopidogrel in Acute Myocardial Infarction at 3-Month Optical Coherence Tomography. ( Ahn, CM; Choi, D; Hong, MK; Hong, SJ; Jang, Y; Kim, BK; Kim, C; Kim, JS; Ko, YG, 2018) |
| "Compared to clopidogrel and prasugrel, ticagrelor reduced neointimal formation, endothelial dysfunction, and peri-strut inflammation." | 3.85 | Effects of ticagrelor on neointimal hyperplasia and endothelial function, compared with clopidogrel and prasugrel, in a porcine coronary stent restenosis model. ( Chang, KS; Hong, YJ; Jeong, MH; Kim, HK; Kim, JH; Kim, MC; Kim, SS; Lim, HC; Lim, KS; Park, KH, 2017) |
| " Long-term administration of cilostazol is more effective in reducing neointimal formation at non-overlapping segments of BESs in a porcine coronary model." | 3.79 | The impact of triple anti-platelet therapy for endothelialization and inflammatory response at overlapping bioabsorbable polymer coated drug-eluting stents in a porcine coronary model. ( Ahn, Y; Cho, JG; Hong, YJ; Jeong, MH; Kang, JC; Kim, JH; Kim, JM; Kim, KH; Lee, KH; Lim, KS; Park, DS; Park, HW; Park, JC; Park, KH; Sim, DS; Yoon, HJ; Yoon, NS, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HK | 1 |
| Jeong, MH | 2 |
| Lim, KS | 2 |
| Kim, JH | 3 |
| Lim, HC | 1 |
| Kim, MC | 1 |
| Hong, YJ | 2 |
| Kim, SS | 1 |
| Park, KH | 2 |
| Chang, KS | 1 |
| Kim, C | 1 |
| Kim, BK | 1 |
| Hong, SJ | 1 |
| Ahn, CM | 1 |
| Kim, JS | 1 |
| Ko, YG | 1 |
| Choi, D | 1 |
| Hong, MK | 1 |
| Jang, Y | 1 |
| Valgimigli, M | 2 |
| Tebaldi, M | 1 |
| Borghesi, M | 1 |
| Vranckx, P | 1 |
| Campo, G | 1 |
| Tumscitz, C | 1 |
| Cangiano, E | 1 |
| Minarelli, M | 1 |
| Scalone, A | 1 |
| Cavazza, C | 1 |
| Marchesini, J | 1 |
| Parrinello, G | 1 |
| Kuramitsu, S | 1 |
| Sonoda, S | 1 |
| Yokoi, H | 1 |
| Iwabuchi, M | 1 |
| Nishizaki, Y | 1 |
| Shinozaki, T | 1 |
| Domei, T | 1 |
| Hyodo, M | 1 |
| Inoue, K | 1 |
| Shirai, S | 1 |
| Ando, K | 1 |
| Nobuyoshi, M | 1 |
| Nishimiya, K | 1 |
| Matsumoto, Y | 1 |
| Uzuka, H | 1 |
| Oyama, K | 1 |
| Tanaka, A | 1 |
| Taruya, A | 1 |
| Ogata, T | 1 |
| Hirano, M | 1 |
| Shindo, T | 1 |
| Hanawa, K | 1 |
| Hasebe, Y | 1 |
| Hao, K | 1 |
| Tsuburaya, R | 1 |
| Takahashi, J | 1 |
| Miyata, S | 1 |
| Ito, K | 1 |
| Akasaka, T | 1 |
| Shimokawa, H | 1 |
| Gargiulo, G | 1 |
| Ariotti, S | 1 |
| Santucci, A | 1 |
| Piccolo, R | 1 |
| Baldo, A | 1 |
| Franzone, A | 1 |
| Magnani, G | 1 |
| Marino, M | 1 |
| Esposito, G | 1 |
| Windecker, S | 1 |
| Zuliani Mauro, MF | 1 |
| Mangione, JA | 1 |
| Costa, JR | 2 |
| Costa, R | 2 |
| Piva E Mattos, LA | 1 |
| Staico, R | 2 |
| Feres, F | 2 |
| Siqueira, D | 1 |
| Sousa, A | 2 |
| Abizaid, A | 2 |
| Cui, S | 1 |
| Lü, SZ | 1 |
| Chen, YD | 1 |
| He, GX | 1 |
| Yan, HB | 1 |
| Meng, LJ | 1 |
| Liu, H | 1 |
| Song, XT | 1 |
| Jin, ZN | 1 |
| Ge, CJ | 1 |
| Hara, M | 1 |
| Nishino, M | 1 |
| Taniike, M | 1 |
| Makino, N | 1 |
| Kato, H | 1 |
| Egami, Y | 1 |
| Shutta, R | 1 |
| Tanouchi, J | 1 |
| Yamada, Y | 1 |
| Collet, CA | 1 |
| Chamié, D | 1 |
| Siquera, D | 1 |
| Obregon, J | 1 |
| Sousa, JE | 1 |
| Kim, JM | 1 |
| Park, DS | 1 |
| Lee, KH | 1 |
| Sim, DS | 1 |
| Yoon, HJ | 1 |
| Yoon, NS | 1 |
| Kim, KH | 1 |
| Park, HW | 1 |
| Ahn, Y | 1 |
| Cho, JG | 1 |
| Park, JC | 1 |
| Kang, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PROlonging Dual Antiplatelet Treatment In Patients With Coronary Artery Disease After Graded Stent-induced Intimal Hyperplasia studY[NCT00611286] | Phase 4 | 1,700 participants (Anticipated) | Interventional | 2006-12-31 | Completed | ||
| Short-term Outcomes of Elective High-risk PCI With Extracorporeal Membrane Oxygenation Support: a Single-centre Registry[NCT05387902] | 25 participants (Actual) | Observational [Patient Registry] | 2022-02-03 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for ticlopidine and Neointima
6 other studies available for ticlopidine and Neointima
| Article | Year |
|---|---|
Effects of ticagrelor on neointimal hyperplasia and endothelial function, compared with clopidogrel and prasugrel, in a porcine coronary stent restenosis model.
Topics: Adenosine; Animals; Clopidogrel; Coronary Restenosis; Drug-Eluting Stents; Endothelium, Vascular; Hy | 2017 |
Long-term coronary arterial response to biodegradable polymer biolimus-eluting stents in comparison with durable polymer sirolimus-eluting stents and bare-metal stents: five-year follow-up optical coherence tomography study.
Topics: Absorbable Implants; Aged; Aged, 80 and over; Atherosclerosis; Coronary Angiography; Coronary Vessel | 2014 |
Accuracy of optical frequency domain imaging for evaluation of coronary adventitial vasa vasorum formation after stent implantation in pigs and humans - a validation study - .
Topics: Adventitia; Aged; Aged, 80 and over; Animals; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vess | 2015 |
[Efficacy of stents coated with antibody against CD105 on preventing restenosis and thrombosis in minipigs].
Topics: Animals; Antibodies; Antigens, CD; Aspirin; Clopidogrel; Coronary Restenosis; Endothelial Cells; Neo | 2010 |
Serial angioscopic evaluation of neointimal coverage and incidence of thrombus formation after Paclitaxel-eluting stent implantation: comparison between 6- and 18-month follow-up.
Topics: Aged; Angioscopy; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Health | 2011 |
The impact of triple anti-platelet therapy for endothelialization and inflammatory response at overlapping bioabsorbable polymer coated drug-eluting stents in a porcine coronary model.
Topics: Absorbable Implants; Animals; Aspirin; Cilostazol; Clopidogrel; Coated Materials, Biocompatible; Cor | 2013 |